Deep Bio Presents Research Results of AI-based Cancer Diagnosis and Prognosis at the AACR Annual Meeting 2022 Five abstracts in prostate and breast cancers, Deep Bio’s main research areas, are presented during the online sessions. SEOUL,...

Tempus, a leader in artificial intelligence and precision medicine, today announced the launch of Edge, an innovative platform that allows pathologists to access developing AI models intended to identify specimens with potentially actionable...

Ultivue, an industry leader in multiplexing tools for tissue biomarker analysis, and Paige, the global leader in AI-based diagnostic software in pathology, today announced a partnership to collaborate on the co-development and co-marketing of...

NEW ORLEANS – An artificial intelligence (AI) model trained using sequential health information derived from electronic health records identified a subset of individuals with a 25-fold risk of developing pancreatic cancer within three to 36...

Mountain View, California, April 11, 2022 – Crosscope Inc. a leading provider of AI-enabled digital pathology software and Waleed Pharmacy & Stores LLC an Omar Zawawi Establishment (OMZEST) group company focused on bringing healthcare,...

aetherAI Machine Learning Approach for Classification of Primary Intestinal T-Cell Lymphomas Published in Cancers TAIPEI, TAIWAN, April 6, 2022 /EINPresswire.com/ -- aetherAI—Asia’s leading medical image AI solution provider focused on...